Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy

CompletedOBSERVATIONAL
Enrollment

1,084

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

No intervention

No intervention

Trial Locations (57)

12205

GSK Investigational Site, Albany

15205

GSK Investigational Site, Clairton

15243

GSK Investigational Site, Pittsburgh

25249

GSK Investigational Site, Birmingham

27103

GSK Investigational Site, Winston-Salem

27609

GSK Investigational Site, Raleigh

28117

GSK Investigational Site, Mooresville

28144

GSK Investigational Site, Salisbury

28401

GSK Investigational Site, Wilmington

29303

GSK Investigational Site, Spartanburg

29340

GSK Investigational Site, Gaffney

29379

GSK Investigational Site, Union

29464

GSK Investigational Site, Mt. Pleasant

29615

GSK Investigational Site, Greenville

29621

GSK Investigational Site, Anderson

29650

GSK Investigational Site, Easley

32720

GSK Investigational Site, DeLand

32789

GSK Investigational Site, Winter Park

32927

GSK Investigational Site, Cocoa

33032

GSK Investigational Site, Naranja

33143

GSK Investigational Site, South Miami

33183

GSK Investigational Site, Miami

33186

GSK Investigational Site, Miami

33321

GSK Investigational Site, Tamarac

33613

GSK Investigational Site, Tampa

33770

GSK Investigational Site, Largo

37601

GSK Investigational Site, Johnson City

38358

GSK Investigational Site, Milan

44718

GSK Investigational Site, Canton

45231

GSK Investigational Site, Cincinnati

45439

GSK Investigational Site, Dayton

46229

GSK Investigational Site, Indianapolis

47711

GSK Investigational Site, Evansville

55904

GSK Investigational Site, Rochester

70115

GSK Investigational Site, New Orleans

70584

GSK Investigational Site, Sunset

72205

GSK Investigational Site, Little Rock

73112

GSK Investigational Site, Oklahoma City

73120

GSK Investigational Site, Oklahoma City

75024

GSK Investigational Site, Plano

76309

GSK Investigational Site, Wichita Falls

76542

GSK Investigational Site, Killeen

76712

GSK Investigational Site, Waco

77054

GSK Investigational Site, Houston

78006

GSK Investigational Site, Boerne

80907

GSK Investigational Site, Colorado Springs

80909

GSK Investigational Site, Colorado Springs

85741

GSK Investigational Site, Tucson

91950

GSK Investigational Site, National City

92270

GSK Investigational Site, Rancho Mirage

92506

GSK Investigational Site, Riverside

92704

GSK Investigational Site, Santa Ana

94598

GSK Investigational Site, Walnut Creek

97213

GSK Investigational Site, Portland

06902

GSK Investigational Site, Stamford

04005

GSK Investigational Site, Biddeford

37824-1409

GSK Investigational Site, New Tazewell

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00791518 - Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy | Biotech Hunter | Biotech Hunter